SELEXIPAG TITRATION AND DOSING PATTERNS IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH) IN A REAL-WORLD CLINICAL SETTING: INSIGHTS FROM THE EXPOSURE STUDY

被引：0
|
作者：
Johnson, M. K. [1 ,8 ,9 ]
Lange, T. J. [2 ]
Soederberg, S. [3 ]
Biedermann, P. [4 ]
Muller, A. [4 ]
Luik, K. [5 ]
Escribano, P. [6 ]
Gaine, S. [7 ]
机构：
[1] Golden Jubilee Natl Hosp, Scottish Pulm Vasc Unit, Glasgow, Lanark, Scotland
[2] Univ Med Ctr Regensburg, Regensburg, Germany
[3] Umea Univ, Cardiol & Heart Ctr, Dept Publ Hlth & Clin Med, Umea, Sweden
[4] Actel Pharmaceut Ltd, Allschwil, Switzerland
[5] StatFinn Estonia OU, Tartu, Estonia
[6] Hosp 12 Octubre, CIBERCV, Cardiol Dept, Pulm Hypertens Unit, Madrid, Spain
[7] Mater Misericordiae Univ Hosp, Natl Pulm Hypertens Unit, Dublin, Ireland
[8] Queen Elizabeth Univ Hosp, Glasgow, Lanark, Scotland
[9] Gartnavel Royal Hosp, Glasgow, Lanark, Scotland
来源：
THORAX | 2021年 / 76卷
关键词：
D O I：
10.1136/thorax-2021-BTSabstracts.85
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
S79
引用
收藏
页码：A50 / A51
页数：2
相关论文
共 50 条
  • [1] Selexipag Titration and Dosing Patterns in Patients with Pulmonary Arterial Hypertension (PAH) in a Real-World Clinical Setting: Insights from the EXPOSURE Study
    Lange, T. J.
    Soderberg, S.
    Biedermann, P.
    Muller, A.
    Luik, K.
    Escribano, P.
    Gaine, S. P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [2] REAL-WORLD USE OF SELEXIPAG AND OTHER PULMONARY ARTERIAL HYPERTENSION (PAH) THERAPIES: AN OBSERVATIONAL COHORT STUDY IN PATIENTS WITH PAH (EXPOSURE)
    Muller, A.
    Soderberg, S.
    Escribano, P.
    Biedermann, P.
    Sun, H.
    Lange, T. J.
    Gaine, S.
    VALUE IN HEALTH, 2019, 22 : S602 - S603
  • [3] Real-World Dosing and Titration of Selexipag in Patients with Pulmonary Arterial Hypertension in the SPHERE Registry (SelexiPag: tHe UsErs dRug rEgistry): Interim Analysis
    Chakinala, M. M.
    Kim, N. H.
    Chin, K. M.
    Farber, H. W.
    Highland, K. B.
    Hemnes, A.
    Zhao, C.
    Keating, M.
    Hartline, B.
    McLaughlin, V. V.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [4] Four-strata risk assessment in pulmonary arterial hypertension (PAH) patients treated with selexipag in real-world settings: Insights from EXPOSURE
    Lange, Tobias
    Escribano, Pilar
    Muller, Audrey
    Fontana, Martina
    Soderberg, Stefan
    Gaine, Sean
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [5] Real-world experience of elderly patients with pulmonary arterial hypertension (PAH) initiating selexipag (EXPOSURE/EXTRACT studies)
    Gaine, Sean
    Escribano-Subias, Pilar
    Muller, Audrey
    Fontana, Martina
    Remenova, Tatiana
    Soderberg, Stefan
    Lange, Tobias J.
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [6] Selexipag real-world experience in patients over 75 yrs with pulmonary arterial hypertension (PAH)
    Gaine, Sean
    Escribano, Pilar
    Biedermann, Patricia
    Muller, Audrey
    Sun, Hong
    Soderberg, Stefan
    Lange, Tobias J.
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [7] Survival in Pulmonary Arterial Hypertension (PAH) for 669 Patients Treated with Selexipag in Clinical Practice: Insights from EXPOSURE
    Soderberg, S.
    Subias, P. Escribano
    O'Donovan, C.
    Muller, A.
    Fontana, M.
    Lange, T. J.
    Gaine, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S85 - S85
  • [8] Clinical Characteristics and Treatment Patterns in Patients with Pulmonary Arterial Hypertension (PAH) Initiating Selexipag in the EXPOSURE Observational Study
    Lange, T. J.
    Escribano, P.
    Biedermann, P.
    Muller, A.
    Sun, H.
    Soderberg, S.
    Gaine, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [9] Clinical Characteristics and Treatment Patterns in Patients with Pulmonary Arterial Hypertension (PAH) Initiating Selexipag in the EXPOSURE Observational Study
    Lange, T. J.
    Escribano, P.
    Biedermann, P.
    Muller, A.
    Sun, H.
    Soderberg, S.
    Gaine, S.
    PNEUMOLOGIE, 2021, 75 : S22 - S22
  • [10] Selexipag in patients with pulmonary arterial hypertension associated with connective tissue disease (PAH-CTD): Real-world experience from EXPOSURE
    Gaine, Sean
    Escribano-Subias, Pilar
    Muller, Audrey
    Fernandes, Catarina C.
    Fontana, Martina
    Remenova, Tatiana
    Soderberg, Stefan
    Lange, Tobias J.
    PULMONARY CIRCULATION, 2024, 14 (03)
12345